drugset / Trial / NCT00962039

Anxiety and Recurrent Abdominal Pain in Children

NCT00962039

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to determine whether citalopram is a useful, well-tolerated, and safe treatment for children and adolescents ages 7 to 18 years with functional abdominal pain. The study hypothesis is that citalopram will be better than placebo in producing clinical improvement and reductions in abdominal pain. It is also hypothesized that citalopram and placebo will not differ in terms of safety and tolerability.

Timeline

Start
2004-07
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 20 mg
Subject Citalopram Small molecule 40 mg

Indications